Baclofen clinical decision support

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

1 post / 0 new
Log in or register to post comments
Tue, 12/17/2019 - 12:47
#1
Beth Willis
Beth Willis's picture
Offline
Last seen: 1 week 3 days ago
Joined: 06/08/2015 - 09:16
Baclofen clinical decision support

We are trying to implement clinical decision support for baclofen prescribing due to several cases of excessive dosing & neurotoxicity in our system (particularly with initiation of therapy and in patients with renal impairment.)

We are struggling to build this content to fire appropriately for new starts but not to impact patients already on baclofen therapy (especially for spasticity) so as to avoid causing harm from baclofen withdrawal in those patients.

Any input you can lend from your experiences is appreciated. We use Cerner and would be interested if any of you have already built content around this.

Tags: 

Top